Daniel J. Lippis, CVP, TAVR at Edwards Lifesciences Corp (EW), sold 620 shares at $81.14 ($50K) on 2026-05-18, disclosed to the SEC on 2026-05-18.
Scheduled sale ($50k) by CVP, TAVR under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | SELL | 2026-08-11 | $57K | — | Filing → |
| EW | SELL | 2026-07-10 | $57K | — | Filing → |
| EW | SELL | 2026-06-30 | $57K | — | Filing → |